iRhythm Holdings, Inc. (IRTC)
Nasdaq · Healthcare · Medical Devices
$109.09−1.16%as of Oct 6, 2026, 7:35 AM ET
- Market cap
- $3.6B
- Forward P/E
- 89.9
- 52-week range
- $100.85 – $212.00
- 52-week change
- −37.86%
- EPS (trailing)
- −$0.42
- Analyst rating
- 1.1 Strong buy
- Next earnings
- Nov 5, 2026
Fiscal year to Dec 2025
- Revenue
- $747M (+26.24%)
- Net income
- −$45.0M
- Operating margin
- −7.7%
- Diluted EPS
- −$1.39
- Free cash flow
- $34.5M
From the company’s annual report on SEC EDGAR.
About iRhythm Holdings, Inc.
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data.
Headquarters: San Francisco, United States · 2,400 employees · irhythmtech.com